Ubiquitin-specific protease 26 facilitates endochondral ossification by driving chondrocyte hypertrophy and mineralization.

IF 20.1 1区 医学 Q1 CELL & TISSUE ENGINEERING
Changwei Li,Yiming Xu,Li Zhou,Leilei Chang,Zhou Dan,Yunhe Jiang,Chao Wang,Lianfu Deng,Guoqing Tang
{"title":"Ubiquitin-specific protease 26 facilitates endochondral ossification by driving chondrocyte hypertrophy and mineralization.","authors":"Changwei Li,Yiming Xu,Li Zhou,Leilei Chang,Zhou Dan,Yunhe Jiang,Chao Wang,Lianfu Deng,Guoqing Tang","doi":"10.1038/s41413-026-00517-5","DOIUrl":null,"url":null,"abstract":"Chondrocyte hypertrophy and mineralization are essential for endochondral ossification; however, the mechanisms underlying these processes remain incompletely understood. In this study, we have identified the facilitated role of ubiquitin-specific protease 26 (USP26) in endochondral ossification by stimulating chondrocyte hypertrophy and mineralization. Ultimately, this promotes skeletal development, bone fracture healing, and the occurrence of osteoarthritis. Mechanistically, USP26 decreases FBP2 undergoing K63-linked ubiquitination, leading to a reduction in the protein level of FBP2. This reduction promotes mitochondrial biogenesis and oxidative phosphorylation, thus facilitating chondrocyte hypertrophy and mineralization and aiding in the process of endochondral ossification. Furthermore, our study found that compression loading induces USP26 to initiate chondrocyte hypertrophy and mineralization through the phosphorylation of estrogen receptor-α at serine 118. These findings suggest that USP26, acting as a mechanosensor, facilitates chondrocyte hypertrophy and mineralization by maintaining mitochondrial biogenesis through the reduction of FBP2. Identifying USP26 as a potential therapeutic target for physiological skeletal growth, bone fracture healing, and osteoarthritis.","PeriodicalId":9134,"journal":{"name":"Bone Research","volume":"19 1","pages":""},"PeriodicalIF":20.1000,"publicationDate":"2026-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41413-026-00517-5","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0

Abstract

Chondrocyte hypertrophy and mineralization are essential for endochondral ossification; however, the mechanisms underlying these processes remain incompletely understood. In this study, we have identified the facilitated role of ubiquitin-specific protease 26 (USP26) in endochondral ossification by stimulating chondrocyte hypertrophy and mineralization. Ultimately, this promotes skeletal development, bone fracture healing, and the occurrence of osteoarthritis. Mechanistically, USP26 decreases FBP2 undergoing K63-linked ubiquitination, leading to a reduction in the protein level of FBP2. This reduction promotes mitochondrial biogenesis and oxidative phosphorylation, thus facilitating chondrocyte hypertrophy and mineralization and aiding in the process of endochondral ossification. Furthermore, our study found that compression loading induces USP26 to initiate chondrocyte hypertrophy and mineralization through the phosphorylation of estrogen receptor-α at serine 118. These findings suggest that USP26, acting as a mechanosensor, facilitates chondrocyte hypertrophy and mineralization by maintaining mitochondrial biogenesis through the reduction of FBP2. Identifying USP26 as a potential therapeutic target for physiological skeletal growth, bone fracture healing, and osteoarthritis.
泛素特异性蛋白酶26通过驱动软骨细胞肥大和矿化促进软骨内骨化。
软骨细胞肥大和矿化是软骨内成骨的必要条件;然而,这些过程背后的机制仍然不完全清楚。在这项研究中,我们已经确定了泛素特异性蛋白酶26 (USP26)通过刺激软骨细胞肥大和矿化在软骨内成骨中的促进作用。最终,这会促进骨骼发育、骨折愈合和骨关节炎的发生。机制上,USP26通过k63连锁泛素化降低FBP2,导致FBP2蛋白水平降低。这种减少促进线粒体的生物发生和氧化磷酸化,从而促进软骨细胞肥大和矿化,帮助软骨内成骨过程。此外,我们的研究发现,压缩负荷诱导USP26通过雌激素受体-α丝氨酸118位点的磷酸化启动软骨细胞肥大和矿化。这些发现表明,USP26作为一种机械传感器,通过减少FBP2来维持线粒体生物发生,从而促进软骨细胞肥大和矿化。确定USP26作为生理骨骼生长、骨折愈合和骨关节炎的潜在治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bone Research
Bone Research CELL & TISSUE ENGINEERING-
CiteScore
20.00
自引率
4.70%
发文量
289
审稿时长
20 weeks
期刊介绍: Established in 2013, Bone Research is a newly-founded English-language periodical that centers on the basic and clinical facets of bone biology, pathophysiology, and regeneration. It is dedicated to championing key findings emerging from both basic investigations and clinical research concerning bone-related topics. The journal's objective is to globally disseminate research in bone-related physiology, pathology, diseases, and treatment, contributing to the advancement of knowledge in this field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书